Continuous and bimonthly publication
ISSN (on-line): 1806-3756

Licença Creative Commons
1637
Views
Back to summary
Open Access Peer-Reviewed
Artigo Original

Benzbromarone as adjuvant therapy for cystic fibrosis lung disease: a pilot clinical trial

Benzbromarone as adjuvant therapy for cystic fibrosis lung disease: a pilot clinical trial

Frederico Friedrich1, Lucas Montiel Petry1, Laura de Castro e Garcia1, Marina Puerari Pieta1, Amanda da Silva Meneses1, Luana Braga Bittencourt1, Luiza Fernandes Xavier1, Marcos Otávio Brum Antunes1, Lucas Kich Grun1,2, Magali Lumertz1, Karl Kunzelmann3, Leonardo Araujo Pinto1

1. Escola de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul – PUCRS – Porto Alegre (RS) Brasil.
2. Laboratório de Imunobiologia, Pontifícia Universidade Católica do Rio Grande do Sul – PUCRS – Porto Alegre (RS) Brasil.
3. Physiological Institute, University of Regensburg, Regensburg, Germany.
Submitted: 6 September 2023.
Accepted: 21 December 2023.
Study carried out at the Escola de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul – PUCRS –
Porto Alegre (RS) Brasil.

Correspondence to:
Frederico Friedrich. Escola de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul, Avenida Ipiranga, 6690, CEP 90610-000, Porto Alegre, RS, Brasil.
Fax: 55 51 3320-3312. Tel.: 55 51 3320-3000. E-mail: frederico.friedrich@pucrs.br
Financial support: This study received financial support from the Brazilian Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Office for the Advancement of Higher Education; Funding Code 001).

Indexes

Development by:

© All rights reserved 2024 - Jornal Brasileiro de Pneumologia